Please Wait
Applying Filters...
menu
    • menu
    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

    Stock Recap
    #PipelineProspector

    Menu

    Empagliflozin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,558Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    28/09/2024 Polpharma
    Poland
    		 IMCD Korea Co., Ltd. Su172-9-ND Empagliflozin 2022-01-11 Pharmaceutical Works Polpharma S.A. Poland 19, Pelplinska Street., 83-200 Starogard Gdanski, Poland
    11/10/2024 Dr. Reddy\'s Laboratories
    India
    		 Samjin Pharmaceutical Co., Ltd. No. 574-15-ND(3) Empagliflozin 2024-01-25 Dr. Reddy\'s Laboratories Limited@Aragen Life Sciences Private Limited India CTO-SEZ Process Unit-01, Sector No.\'s 28 to 34, 36 to 37, 40, 50 to 53 & 03, Survey No.\'s 57 to 58, 60, 72 to 73, 76 to 77 & 80, Devunipalavalasa Village, Ranasthalam Mandal, Srikakulam District 532409, Andhra Pradesh, India@Plot No. 28 A, IDA, Nacharam Hyderabad - 500076, Telangana, India